Immunic Inc. (IMUX) Misses Q4 EPS by 53c

Immunic Inc. (NASDAQ: IMUX) reported Q4 EPS of ($0.62), $0.53 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
• NetEase (NTES) call put ratio 1 call to 1.1 puts into quarter results
• Walmart (WMT) call put ratio 1 call to 1.7 puts into quarter results